Head to Head Analysis: Chemours (CC) versus Its Peers

Chemours (NYSE:CC) is one of 295 public companies in the “Chemicals” industry, but how does it weigh in compared to its peers? We will compare Chemours to similar companies based on the strength of its risk, earnings, valuation, analyst recommendations, institutional ownership, dividends and profitability.

Analyst Ratings

This is a breakdown of current ratings and price targets for Chemours and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	2	8	3	0	2.08
Chemours Competitors	3247	12209	14130	518	2.40

Chemours currently has a consensus price target of $17.45, indicating a potential upside of 37.21%. As a group, “Chemicals” companies have a potential upside of 8.87%. Given Chemours’ higher possible upside, equities research analysts clearly believe Chemours is more favorable than its peers.

Profitability

This table compares Chemours and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Chemours	-2.64%	78.76%	1.51%
Chemours Competitors	-61.35%	1.23%	-1.42%

Insider and Institutional Ownership

76.3% of Chemours shares are owned by institutional investors. Comparatively, 47.4% of shares of all “Chemicals” companies are owned by institutional investors. 0.9% of Chemours shares are owned by insiders. Comparatively, 13.7% of shares of all “Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Dividends

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.8%. Chemours pays out -34.3% of its earnings in the form of a dividend. As a group, “Chemicals” companies pay a dividend yield of 3.1% and pay out 104.4% of their earnings in the form of a dividend.

Risk & Volatility

Chemours has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Chemours’ peers have a beta of 0.93, meaning that their average stock price is 7% less volatile than the S&P 500.

Earnings and Valuation

This table compares Chemours and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Chemours	$5.81 billion	-$386.00 million	-12.47
Chemours Competitors	$6.35 billion	$222.31 million	-0.87

Chemours’ peers have higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Chemours peers beat Chemours on 8 of the 15 factors compared.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.